NEOGENOMICS INC's ticker is NEO and the CUSIP is 64049M209. A total of 309 filers reported holding NEOGENOMICS INC in Q4 2021. The put-call ratio across all filers is 0.60 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,868,373 | +190.8% | 233,201 | +280.0% | 0.00% | +300.0% |
| Q2 2023 | $986,248 | -3.5% | 61,372 | +4.5% | 0.00% | 0.0% |
| Q1 2023 | $1,022,193 | +47.6% | 58,713 | -21.7% | 0.00% | 0.0% |
| Q4 2022 | $692,473 | +7.3% | 74,943 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $645,259 | -14.6% | 74,943 | -19.2% | 0.00% | -50.0% |
| Q2 2022 | $756,000 | -32.0% | 92,787 | +1.4% | 0.00% | 0.0% |
| Q1 2022 | $1,112,000 | -61.3% | 91,509 | +8.8% | 0.00% | -66.7% |
| Q4 2021 | $2,871,000 | -29.7% | 84,140 | -0.6% | 0.01% | -25.0% |
| Q3 2021 | $4,084,000 | +8.3% | 84,659 | +1.4% | 0.01% | +14.3% |
| Q2 2021 | $3,770,000 | -10.1% | 83,459 | -4.0% | 0.01% | -12.5% |
| Q1 2021 | $4,194,000 | +3.7% | 86,957 | +15.8% | 0.01% | 0.0% |
| Q4 2020 | $4,044,000 | +88.6% | 75,108 | +29.2% | 0.01% | +60.0% |
| Q3 2020 | $2,144,000 | +17.7% | 58,128 | -1.2% | 0.01% | +25.0% |
| Q2 2020 | $1,822,000 | -6.0% | 58,809 | -16.2% | 0.00% | -20.0% |
| Q1 2020 | $1,938,000 | -5.6% | 70,210 | +0.1% | 0.01% | +25.0% |
| Q4 2019 | $2,052,000 | +83.4% | 70,137 | +19.9% | 0.00% | +100.0% |
| Q3 2019 | $1,119,000 | -10.6% | 58,500 | +2.6% | 0.00% | -33.3% |
| Q2 2019 | $1,251,000 | +44.1% | 57,041 | +34.5% | 0.00% | +50.0% |
| Q1 2019 | $868,000 | +159.9% | 42,412 | +60.0% | 0.00% | +100.0% |
| Q4 2018 | $334,000 | -9.5% | 26,506 | +10.3% | 0.00% | 0.0% |
| Q3 2018 | $369,000 | +17.1% | 24,027 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $315,000 | +31.8% | 24,027 | -18.1% | 0.00% | 0.0% |
| Q1 2018 | $239,000 | -8.1% | 29,333 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $260,000 | -20.2% | 29,333 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $326,000 | +24.0% | 29,333 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $263,000 | +30.8% | 29,333 | +15.4% | 0.00% | – |
| Q1 2017 | $201,000 | -7.8% | 25,412 | 0.0% | 0.00% | -100.0% |
| Q4 2016 | $218,000 | +4.3% | 25,412 | 0.0% | 0.00% | – |
| Q3 2016 | $209,000 | +2.5% | 25,412 | 0.0% | 0.00% | -100.0% |
| Q2 2016 | $204,000 | +19.3% | 25,412 | 0.0% | 0.00% | – |
| Q1 2016 | $171,000 | -14.5% | 25,412 | 0.0% | 0.00% | – |
| Q4 2015 | $200,000 | +37.0% | 25,412 | 0.0% | 0.00% | – |
| Q3 2015 | $146,000 | -20.2% | 25,412 | -24.7% | 0.00% | – |
| Q2 2015 | $183,000 | – | 33,734 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kopp Family Office, LLC | 2,023,355 | $91,395,000 | 37.83% |
| Blue Water Life Science Advisors, LP | 702,222 | $31,719,000 | 11.94% |
| Burrage Capital Management LLC | 147,921 | $6,682,000 | 6.70% |
| PERKINS CAPITAL MANAGEMENT INC | 158,300 | $7,150,000 | 4.06% |
| First Light Asset Management, LLC | 1,148,945 | $51,898,000 | 3.11% |
| Soleus Capital Management, L.P. | 352,007 | $15,900,000 | 2.44% |
| Ranger Investment Management | 832,286 | $37,594,000 | 1.96% |
| Avidity Partners Management LP | 1,367,000 | $61,747,000 | 1.67% |
| Bullseye Asset Management LLC | 108,672 | $4,909,000 | 1.65% |
| Tygh Capital Management, Inc. | 255,541 | $11,543,000 | 1.57% |